Miami Gardens, FL2 Active Studies

Ankylosing Spondylitis Clinical Trials in Miami Gardens, FL

Find 2 actively recruiting ankylosing spondylitis clinical trials in Miami Gardens, FL. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
406
Enrolling

Recruiting Ankylosing Spondylitis Studies in Miami Gardens

About Ankylosing Spondylitis Clinical Trials in Miami Gardens

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Miami Gardens, FL. These studies are seeking a combined 406 participants. Research is being sponsored by MapLight Therapeutics, Resolve Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Miami Gardens — FAQ

Are there ankylosing spondylitis clinical trials in Miami Gardens?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Miami Gardens, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami Gardens?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami Gardens research site will contact you about next steps.

Are clinical trials in Miami Gardens free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami Gardens studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Miami Gardens are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov